|
|
Article: Researchers at Medical College of Georgia, Medical College target angiotensins.
- Article from:
- Biotech Week
- Article date:
- April 1, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
According to a study from the United States, "Spironolactone and eplerenone are widely used as mineralocorticoid antagonists. Spironolactone has several nonspecific actions including inhibition of androgen receptor and steroid hormone biosynthesis."
"While studies have shown that eplerenone does not exhibit nonspecific actions on androgen receptor, its effects on steroid hormone production have not been reported. Herein, the effects of eplerenone (0.1-30 mc M) and spironolactone (0.1-30 mc M) on steroid production were examined in human adrenocortical H295R cells. Spironolactone inhibited basal production of cortisol (91%) and aldosterone (53%). Treatment of ...
Related newspaper, magazine, and journal articles:
|
|
Article: Metabolic Research, Inc. Increases GNC ...
Biotech Week;
August 5, 2009 ;
463 words
...Metabolic Research, Inc. (OTC:MTBR) announced ... Fitness Formula products (see also Metabolic Research, Inc.). Stemulite& ... through their internet store. Metabolic Research, Inc. President and Chief Executive ...
|
|